BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20555295)

  • 1. ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression.
    Sarginson JE; Lazzeroni LC; Ryan HS; Ershoff BD; Schatzberg AF; Murphy GM
    Pharmacogenet Genomics; 2010 Aug; 20(8):467-75. PubMed ID: 20555295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.
    Uhr M; Tontsch A; Namendorf C; Ripke S; Lucae S; Ising M; Dose T; Ebinger M; Rosenhagen M; Kohli M; Kloiber S; Salyakina D; Bettecken T; Specht M; Pütz B; Binder EB; Müller-Myhsok B; Holsboer F
    Neuron; 2008 Jan; 57(2):203-9. PubMed ID: 18215618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis.
    Breitenstein B; Brückl TM; Ising M; Müller-Myhsok B; Holsboer F; Czamara D
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jun; 168B(4):274-83. PubMed ID: 25847751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
    Ray A; Tennakoon L; Keller J; Sarginson JE; Ryan HS; Murphy GM; Lazzeroni LC; Trivedi MH; Kocsis JH; DeBattista C; Schatzberg AF
    Pharmacogenomics J; 2015 Aug; 15(4):332-9. PubMed ID: 25487678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.
    Kato M; Fukuda T; Serretti A; Wakeno M; Okugawa G; Ikenaga Y; Hosoi Y; Takekita Y; Mandelli L; Azuma J; Kinoshita T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):398-404. PubMed ID: 17913323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
    Breitenstein B; Scheuer S; Pfister H; Uhr M; Lucae S; Holsboer F; Ising M; Brückl TM
    CNS Spectr; 2014 Apr; 19(2):165-75. PubMed ID: 23880209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.
    Singh AB; Bousman CA; Ng CH; Byron K; Berk M
    Transl Psychiatry; 2012 Nov; 2(11):e198. PubMed ID: 23188198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder.
    Simoons M; Mulder H; Appeldoorn JTY; Risselada AJ; Schene AH; van Schaik RHN; van Roon EN; Ruhé EG
    Psychiatr Genet; 2020 Feb; 30(1):19-29. PubMed ID: 31634334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression.
    Murphy GM; Sarginson JE; Ryan HS; O'Hara R; Schatzberg AF; Lazzeroni LC
    Pharmacogenet Genomics; 2013 Jun; 23(6):301-13. PubMed ID: 23619509
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Santos M; Lima L; Carvalho S; Brandão A; Barroso F; Cruz A; Medeiros R
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
    Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
    Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
    Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study.
    Breitenstein B; Scheuer S; Brückl TM; Meyer J; Ising M; Uhr M; Holsboer F
    J Psychiatr Res; 2016 Feb; 73():86-95. PubMed ID: 26704739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study.
    Magarbeh L; Hassel C; Choi M; Islam F; Marshe VS; Zai CC; Zuberi R; Gammal RS; Men X; Scherf-Clavel M; Enko D; Frey BN; Milev R; Soares CN; Parikh SV; Placenza F; Strother SC; Hassel S; Taylor VH; Leri F; Blier P; Farzan F; Lam RW; Turecki G; Foster JA; Rotzinger S; Kloiber S; Kennedy JL; Kennedy SH; Bousman CA; Müller DJ
    Clin Pharmacol Ther; 2023 Jul; 114(1):88-117. PubMed ID: 36681895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FKBP5 polymorphisms and antidepressant response in geriatric depression.
    Sarginson JE; Lazzeroni LC; Ryan HS; Schatzberg AF; Murphy GM
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):554-560. PubMed ID: 19676097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients.
    Huang X; Yu T; Li X; Cao Y; Li X; Liu B; Yang F; Li W; Zhao X; Feng G; Zhang X; Dong Z; He L; Sun X; He G
    Pharmacogenomics; 2013 Nov; 14(14):1723-30. PubMed ID: 24192121
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Gao YL; He B
    DNA Cell Biol; 2018 Dec; 37(12):1055-1060. PubMed ID: 30256659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design.
    Geers LM; Ochi T; Vyalova NM; Losenkov IS; Paderina DZ; Pozhidaev IV; Simutkin GG; Bokhan NA; Wilffert B; Touw DJ; Loonen AJM; Ivanova SA
    Hum Psychopharmacol; 2022 May; 37(3):e2826. PubMed ID: 34788473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?
    Zubiaur P; Saiz-Rodríguez M; Koller D; Ovejero-Benito MC; Wojnicz A; Abad-Santos F
    Pharmacogenomics; 2018 Nov; 19(16):1285-1297. PubMed ID: 30334473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients.
    Dragonas C; Wagner JT; Heppner HJ; Bertsch T; Muhlberg W; Wicklein S; Pahl A; Diewald C; Bachmakov I; Sieber CC; Fromm MF
    Eur J Clin Pharmacol; 2008 Apr; 64(4):367-72. PubMed ID: 18080812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.